MX340921B - Compensacion basada en la pendiente que incluye señales de salida secundarias. - Google Patents

Compensacion basada en la pendiente que incluye señales de salida secundarias.

Info

Publication number
MX340921B
MX340921B MX2012014282A MX2012014282A MX340921B MX 340921 B MX340921 B MX 340921B MX 2012014282 A MX2012014282 A MX 2012014282A MX 2012014282 A MX2012014282 A MX 2012014282A MX 340921 B MX340921 B MX 340921B
Authority
MX
Mexico
Prior art keywords
output signals
slope
secondary output
including secondary
analyte concentrations
Prior art date
Application number
MX2012014282A
Other languages
English (en)
Spanish (es)
Other versions
MX2012014282A (es
Inventor
Huan-Ping Wu
Dijia Huang
Original Assignee
Ascensia Diabetes Care Holdings Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ascensia Diabetes Care Holdings Ag filed Critical Ascensia Diabetes Care Holdings Ag
Publication of MX2012014282A publication Critical patent/MX2012014282A/es
Publication of MX340921B publication Critical patent/MX340921B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28—Electrolytic cell components
    • G01N27/30—Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274—Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/48707—Physical analysis of biological material of liquid biological material by electrical means
    • G01N33/48714—Physical analysis of biological material of liquid biological material by electrical means for determining substances foreign to the organism, e.g. drugs or heavy metals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
MX2012014282A 2010-06-07 2011-05-27 Compensacion basada en la pendiente que incluye señales de salida secundarias. MX340921B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35198810P 2010-06-07 2010-06-07
PCT/US2011/038329 WO2011156152A1 (en) 2010-06-07 2011-05-27 Slope-based compensation including secondary output signals

Publications (2)

Publication Number Publication Date
MX2012014282A MX2012014282A (es) 2013-01-24
MX340921B true MX340921B (es) 2016-08-01

Family

ID=44501672

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012014282A MX340921B (es) 2010-06-07 2011-05-27 Compensacion basada en la pendiente que incluye señales de salida secundarias.
MX2016005536A MX369764B (es) 2010-06-07 2011-05-27 Compensación basada en la pendiente que incluye señales de salida secundarias.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2016005536A MX369764B (es) 2010-06-07 2011-05-27 Compensación basada en la pendiente que incluye señales de salida secundarias.

Country Status (12)

Country Link
US (3) US9164076B2 (enExample)
EP (3) EP3104176B1 (enExample)
JP (1) JP5856154B2 (enExample)
KR (2) KR102068949B1 (enExample)
CN (1) CN103210310B (enExample)
BR (1) BR112012031166A2 (enExample)
CA (1) CA2798938C (enExample)
ES (1) ES2700100T3 (enExample)
MX (2) MX340921B (enExample)
RU (1) RU2577711C2 (enExample)
SG (2) SG186179A1 (enExample)
WO (1) WO2011156152A1 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8529751B2 (en) 2006-03-31 2013-09-10 Lifescan, Inc. Systems and methods for discriminating control solution from a physiological sample
US8778168B2 (en) 2007-09-28 2014-07-15 Lifescan, Inc. Systems and methods of discriminating control solution from a physiological sample
US8603768B2 (en) 2008-01-17 2013-12-10 Lifescan, Inc. System and method for measuring an analyte in a sample
US8551320B2 (en) 2008-06-09 2013-10-08 Lifescan, Inc. System and method for measuring an analyte in a sample
EP2550530A1 (en) * 2010-03-22 2013-01-30 Bayer HealthCare LLC Residual compensation for a biosensor
KR102068949B1 (ko) * 2010-06-07 2020-01-21 바이엘 헬쓰케어 엘엘씨 2차 출력 신호를 포함하는 기울기-기반 보상
EP3586831A1 (en) 2011-09-21 2020-01-01 Ascensia Diabetes Care Holdings AG Analysis compensation including segmented signals
US9903830B2 (en) 2011-12-29 2018-02-27 Lifescan Scotland Limited Accurate analyte measurements for electrochemical test strip based on sensed physical characteristic(s) of the sample containing the analyte
US8709232B2 (en) * 2012-04-30 2014-04-29 Cilag Gmbh International Analyte measurement technique and system
MX355854B (es) * 2012-07-27 2018-05-03 Ascensia Diabetes Care Holdings Ag Sistema y metodo para detectar sensores utilizados y secados.
HK1221771A1 (zh) * 2013-03-14 2017-06-09 安晟信医疗科技控股公司 分析物浓度测定的标准化校准
CN105283765B (zh) * 2013-03-14 2018-01-16 安晟信医疗科技控股公司 分析物浓度测定的系统误差补偿
US9459231B2 (en) 2013-08-29 2016-10-04 Lifescan Scotland Limited Method and system to determine erroneous measurement signals during a test measurement sequence
US9243276B2 (en) 2013-08-29 2016-01-26 Lifescan Scotland Limited Method and system to determine hematocrit-insensitive glucose values in a fluid sample
EP3295159B1 (en) 2015-05-15 2021-12-01 Ascensia Diabetes Care Holdings AG Improved biosensor system analyte measurement
CN105021805B (zh) * 2015-08-21 2018-03-06 三诺生物传感股份有限公司 一种人体生理参数检测结果的校正方法
CN109690304A (zh) 2016-07-12 2019-04-26 安晟信医疗科技控股公司 通过使用来自两个电极的交替输出信号进行电化学分析的方法
EP3548881A1 (en) 2016-12-05 2019-10-09 Ascensia Diabetes Care Holdings AG Risk factor monitoring
JP7494194B2 (ja) 2019-02-05 2024-06-03 アセンシア・ディアベティス・ケア・ホールディングス・アーゲー 連続的分析物感知および自動較正のセンサ動作を精査するための装置および方法
EP3928089B1 (en) 2019-02-22 2025-05-14 Ascensia Diabetes Care Holdings AG Method and system for glucose concentration monitoring using harmonic relationships
US11963763B2 (en) 2019-09-10 2024-04-23 Ascensia Diabetes Care Holdings Ag Methods and apparatus information gathering, error detection and analyte concentration determination during continuous analyte sensing

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431004A (en) 1981-10-27 1984-02-14 Bessman Samuel P Implantable glucose sensor
US4750496A (en) 1987-01-28 1988-06-14 Xienta, Inc. Method and apparatus for measuring blood glucose concentration
US5243516A (en) 1989-12-15 1993-09-07 Boehringer Mannheim Corporation Biosensing instrument and method
US5508171A (en) 1989-12-15 1996-04-16 Boehringer Mannheim Corporation Assay method with enzyme electrode system
FR2701117B1 (fr) 1993-02-04 1995-03-10 Asulab Sa Système de mesures électrochimiques à capteur multizones, et son application au dosage du glucose.
US5366609A (en) 1993-06-08 1994-11-22 Boehringer Mannheim Corporation Biosensing meter with pluggable memory key
IE72524B1 (en) 1994-11-04 1997-04-23 Elan Med Tech Analyte-controlled liquid delivery device and analyte monitor
US6153069A (en) 1995-02-09 2000-11-28 Tall Oak Ventures Apparatus for amperometric Diagnostic analysis
US5620579A (en) 1995-05-05 1997-04-15 Bayer Corporation Apparatus for reduction of bias in amperometric sensors
AUPN661995A0 (en) * 1995-11-16 1995-12-07 Memtec America Corporation Electrochemical cell 2
US5723284A (en) 1996-04-01 1998-03-03 Bayer Corporation Control solution and method for testing the performance of an electrochemical device for determining the concentration of an analyte in blood
AU6157898A (en) 1997-02-06 1998-08-26 E. Heller & Company Small volume (in vitro) analyte sensor
US6391558B1 (en) 1997-03-18 2002-05-21 Andcare, Inc. Electrochemical detection of nucleic acid sequences
US6391645B1 (en) 1997-05-12 2002-05-21 Bayer Corporation Method and apparatus for correcting ambient temperature effect in biosensors
US5798031A (en) 1997-05-12 1998-08-25 Bayer Corporation Electrochemical biosensor
EP0990151A2 (en) 1997-06-16 2000-04-05 ELAN CORPORATION, Plc Methods of calibrating and testing a sensor for (in vivo) measurement of an analyte and devices for use in such methods
US7494816B2 (en) * 1997-12-22 2009-02-24 Roche Diagnostic Operations, Inc. System and method for determining a temperature during analyte measurement
JP3260739B2 (ja) 1997-12-22 2002-02-25 ロシュ ダイアグノスティックス コーポレーション 生物学的流体の医学的に有意な成分の濃度を測定する装置および方法
US6233471B1 (en) 1998-05-13 2001-05-15 Cygnus, Inc. Signal processing for measurement of physiological analysis
AU3849799A (en) 1998-05-20 1999-12-06 Arkray, Inc. Method and apparatus for electrochemical measurement using statistical technique
US6475372B1 (en) 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
WO2001021827A1 (en) 1999-09-20 2001-03-29 Roche Diagnostics Corporation Small volume biosensor for continuous analyte monitoring
JP4050434B2 (ja) 1999-11-29 2008-02-20 松下電器産業株式会社 サンプルの弁別方法
WO2002057768A1 (fr) 2001-01-17 2002-07-25 Arkray, Inc. Procede d'analyse quantitative et dispositif d'analyse quantitative utilisant un capteur
JP4246633B2 (ja) 2001-10-12 2009-04-02 アークレイ株式会社 濃度測定方法および濃度測定装置
AU2003234944A1 (en) 2002-08-27 2004-03-18 Bayer Healthcare, Llc Methods of Determining Glucose Concentration in Whole Blood Samples
US7132041B2 (en) 2003-02-11 2006-11-07 Bayer Healthcare Llc Methods of determining the concentration of an analyte in a fluid test sample
US7488601B2 (en) 2003-06-20 2009-02-10 Roche Diagnostic Operations, Inc. System and method for determining an abused sensor during analyte measurement
US7452457B2 (en) * 2003-06-20 2008-11-18 Roche Diagnostics Operations, Inc. System and method for analyte measurement using dose sufficiency electrodes
ES2709991T3 (es) 2003-08-21 2019-04-22 Agamatrix Inc Método y aparato para el análisis de propiedades electroquímicas
JP4449431B2 (ja) 2003-11-19 2010-04-14 パナソニック株式会社 基質濃度の測定方法
JP2005156316A (ja) * 2003-11-25 2005-06-16 Toshiba Corp マイクロ波式濃度計
RU2371707C2 (ru) * 2004-02-06 2009-10-27 БАЙЕР ХЕЛТКЭР ЭлЭлСи Электрохимический биодатчик
JP4689601B2 (ja) 2004-04-19 2011-05-25 パナソニック株式会社 血液成分の測定方法、それに用いるバイオセンサおよび測定装置
EP1742054A4 (en) 2004-04-28 2008-01-16 Japan Science & Tech Agency BIOCHIP PRODUCTION PROCESS, BIOCHIP, BIOCHIP ANALYSIS DEVICE, BIOCHIP ANALYSIS PROCEDURE
RU2006144458A (ru) 2004-05-14 2008-06-20 БАЙЕР ХЕЛТКЭР ЭлЭлСи (US) Способы осуществления корректировки по гематокриту в анализах глюкозы и устройства для этого
AU2005295106B2 (en) 2004-10-12 2012-03-15 Bayer Healthcare Llc Concentration determination in a diffusion barrier layer
GB0501826D0 (en) 2005-01-28 2005-03-09 Melys Diagnostics Ltd Apparatus for measurement of analyte concentration
US20090067150A1 (en) 2005-03-22 2009-03-12 Tomoaki Ito Protection Film for Preventing Leakage of Information, Portable Pouch, Card Case, and Information-Leakage Preventing Plate
US7517439B2 (en) 2005-04-15 2009-04-14 Agamatrix, Inc. Error detection in analyte measurements based on measurement of system resistance
EP3483599A1 (en) 2005-07-20 2019-05-15 Ascensia Diabetes Care Holdings AG Methods for measuring the concentration of an analyte in solution and for calibrating the measurement as well as handheld devices therefor
CA2616402A1 (en) 2005-07-26 2007-02-01 Bayer Healthcare Llc Method and system for checking an electromechanical biosensor
CN103048442B (zh) 2005-09-30 2015-04-08 拜尔健康护理有限责任公司 门控伏特安培法
RU2455925C2 (ru) * 2006-02-27 2012-07-20 БАЙЕР ХЕЛТКЭА ЭлЭлСи Определение исследуемого вещества с поправкой на температуру для систем биодатчиков
JP5121822B2 (ja) * 2006-05-08 2013-01-16 バイエル・ヘルスケア・エルエルシー バイオセンサ用異常出力検出システム
CN101495855B (zh) * 2006-07-05 2013-04-17 松下电器产业株式会社 液体试样测定方法及装置
BRPI0717430A2 (pt) * 2006-09-22 2013-11-12 Bayer Healthcare Llc Sistema de biossensor tendo estabilidade e desempenho de hematócritos maiores
US20080248581A1 (en) 2007-04-06 2008-10-09 Bayer Healthcare Llc Method for performing correction of blood glucose assay bias using blood hemoglobin concentration
RU2706691C2 (ru) * 2007-12-10 2019-11-20 Асцензия Диабетс Кэар Холдингс АГ Способ определения концентрации аналита
CN101214152A (zh) * 2008-01-22 2008-07-09 天津市先石光学技术有限公司 人体血糖浓度的微创、动态、连续检测方法
RU2509304C2 (ru) * 2008-12-08 2014-03-10 БАЙЕР ХЕЛТКЭА ЭлЭлСи Биосенсорная система с корректировкой сигнала
KR102068949B1 (ko) * 2010-06-07 2020-01-21 바이엘 헬쓰케어 엘엘씨 2차 출력 신호를 포함하는 기울기-기반 보상

Also Published As

Publication number Publication date
HK1181850A1 (en) 2013-11-15
US20180275089A1 (en) 2018-09-27
JP2013528289A (ja) 2013-07-08
CN103210310A (zh) 2013-07-17
EP3104176A1 (en) 2016-12-14
JP5856154B2 (ja) 2016-02-09
WO2011156152A1 (en) 2011-12-15
EP2577302B1 (en) 2016-08-03
EP2577302B8 (en) 2016-10-26
CN103210310B (zh) 2015-03-18
CA2798938C (en) 2018-08-07
MX369764B (es) 2019-11-21
KR20190042767A (ko) 2019-04-24
MX2012014282A (es) 2013-01-24
KR102068949B1 (ko) 2020-01-21
US10921278B2 (en) 2021-02-16
RU2012157320A (ru) 2014-07-20
BR112012031166A2 (pt) 2018-02-27
EP3104176B1 (en) 2018-08-29
CA2798938A1 (en) 2011-12-15
US9164076B2 (en) 2015-10-20
SG10201507109TA (en) 2015-10-29
EP2577302A1 (en) 2013-04-10
RU2577711C2 (ru) 2016-03-20
US9995702B2 (en) 2018-06-12
KR101971233B1 (ko) 2019-04-22
US20110301857A1 (en) 2011-12-08
ES2700100T3 (es) 2019-02-14
SG186179A1 (en) 2013-01-30
US20150377819A1 (en) 2015-12-31
EP3431986A1 (en) 2019-01-23
KR20130109088A (ko) 2013-10-07

Similar Documents

Publication Publication Date Title
MX369764B (es) Compensación basada en la pendiente que incluye señales de salida secundarias.
MX2010006392A (es) Compensacion basada en la pendiente.
MX368104B (es) Compensacion residual para un biosensor.
MX2014003015A (es) Biosensor con compensacion de error.
MX367439B (es) Sistema de gestion de llenado insuficiente para un biosensor.
WO2009104016A3 (en) Methods of calibrating a sensor in a patient monitoring system
MX2011013404A (es) Espectrometro sin cubeta.
WO2008130727A3 (en) Background compensation by multiple-peak measurements for absorption spectroscopy-based gas sensing
EP4324399A3 (en) Advanced analyte sensor calibration and error detection
GB2498494A (en) System and method for distributed environmental parameter measurement
IN2014MN02008A (enExample)
IL205499A0 (en) Optical sensor for determining the concentration of an analyte
EP4397242A3 (en) Analyte sensors with a sensing surface having small sensing spots
WO2011071256A3 (en) Centrifugal micro-fluidic structure for measuring glycated hemoglobin, centrifugal micro-fluidic device for measuring glycated hemoglobin, and method for measuring glycated hemoglobin
ATE545014T1 (de) Verfahren zur detektion von verunreinigungen einer optischen messküvette
IN2014KN02807A (enExample)
MX2019005697A (es) Medicion de longitud de onda secuencial multiple de una muestra liquida.
WO2010019283A3 (en) Method for measuring dopant concentration during plasma ion implantation
WO2007140185A3 (en) Methods for non-invasive analyte measurement
EP2212700B8 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP4461219A3 (en) Analyte level calibration using baseline analyte level
WO2012027266A3 (en) Methods for dectecting embryonic stem cells, induced pluripotent stem cells, or cells undergoing reprogramming to produce induced pluripotent stem cells
GB201113435D0 (en) Sensor calibration
EP3915584A3 (en) Immunoassay of s-adenosylmethionine using analogs thereof and personalized therapeutics
MY149500A (en) The quantitative determination of risedronate in urine by spe-lc-ms-ms

Legal Events

Date Code Title Description
FG Grant or registration